medigraphic.com

2009, Number 4

Next >>

Med Sur 2009; 16 (4)

Escrutinio de diabetes gestacional: frecuencia de resultados anormales en el Hospital Médica Sur

Aceves-Capri AE, Pérez-Jáuregui J

Language: Spanish
References: 11
Page: 168-171
PDF size: 41.26 Kb.


ABSTRACT

Aim. To know the frequency of positive screening tests for gestational diabetes in our laboratory using two cut off levels: ≥ 140 and ≥ 130 mg/dL of glucose. Background. The screening test for gestational diabetes mellitus allows the early identification of women at risk of having GDM. The screening takes place between 24-28 weeks of gestation. The cut off level more widely accepted is ≥ 140 mg/dL of glucose. Material and methods We included all women who had a screening test for gestational diabetes during January 1st 2002 to March 31st; 2008. We analyzed the frequency of positive screening tests taking as cut off levels ≥ 140 mg/dL and ≥ 130 mg/dL of glucose. Results. 871 women had the screening test during the given period of time. The frequency of abnormal results was 30.30% for the ≥ 140 mg/dL cut off level, and 43.97% when using ≥ 130 mg/ dL. Conclusions. The frequency of abnormal results of the screening test for gestational diabetes in our served population is similar to that described in the literature. Such frequency was higher when the cut off level was diminished to ≥ 130 mg/dL of glucose. Our results are a precedent to further studies about this subject in our medical institution.


REFERENCES

  1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26 (Suppl. 1): S5-S16.

  2. Esakoff TF, Cheng YW, Caughey AB. Screening for gestational diabetes: different cut-offs for different ethnicities? Am J Obstet Gynecol 2005; 193: 1040-4.

  3. U.S. Preventive Services Task Force. Screening for gestational diabetes. Agency for Healthcare Research and Quality 2003; Pub. 03-516A, 1-4.

  4. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27(Suppl. 1): S88-S90.

  5. Perucchini D, Fischer U, Spinas GA, Huch R, Huch A, et al. Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. BMJ 1999; 319: 812-15.

  6. Ferrera A, Quesenberry CP, Hedderson MM, Selby JV. Prevalence of gestational diabetes mellitus detected by the National Diabetes Data Group or the Carpenter and Coustan plasma glucose thresholds. Diabetes Care 2002; 25(9): 1625-9.

  7. Ramírez TMA. Diabetes mellitus gestacional. Experiencia en una institución de tercer nivel de atención. Ginecol Obstet Mex 2005; 73: 484-91.

  8. Yogev Y, Langer O, Xenakis EMJ, Rosenn B. Glucose screening in Mexican-American women. Obstet Gynecol 2004; 103: 1241-5.

  9. Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes: the consecuences of not treating. Am J Obstet Gynecol 2005; 192: 989-97.

  10. Sistema Nacional de Información en Salud (SINAIS) [sitio de Internet] Mortalidad. Información 2000-2005. Principales causas de mortalidad general. Disponible en: http:// www.salud.gob.mx/apps/htdocs/estadisticas/mortalidad/tabs/ m_005.xls

  11. Sistema Nacional de Información en Salud (SINAIS) [sitio de Internet] Mortalidad. Información 2000-2005. Principales causas de mortalidad en mujeres. Disponible en: http:// www.salud.gob.mx/apps/htdocs/estadisticas/mortalidad/tabs/ m_011.xls




2020     |     www.medigraphic.com